Brief: China Pioneer Pharma Says Urofollitropin For Injection Been Granted Re-Registration Approval From NMPA
Jan 20 (Reuters) - China Pioneer Pharma Holdings Ltd
1345.HK :
* CHINA PIONEER PHARMA HOLDINGS LTD- UROFOLLITROPIN FOR
INJECTION
BEEN GRANTED RE-REGISTRATION APPROVAL FROM NMPA OF PRC ON JAN 14
Source text for Eikon: ID:nHKS7ycS1x
Further company coverage: 1345.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Pioneer Holding
See all newsBrief: Shanghai Pioneer Posts HY Revenue Rmb602.8 Million
Brief: Shanghai Pioneer Net Profit Rmb105.1 Million In 2025
Brief: Shanghai Pioneer To Be Exclusive Distributor Of Labo Hair Loss Vials In China
Brief: Shanghai Pioneer Logs H1 Gross Profit RMB 303 Mln
Brief: Shanghai Pioneer Expects 45%-48% Net Profit Decrease For HY